The Ministry of Health, Labor and Welfare officially approved the use of the new coronavirus vaccine developed by the American pharmaceutical company Novabacs for people aged 18 and over on the 19th.

This vaccine, which is the fourth type in Japan, has a different mechanism from Pfizer and Moderna, and the Ministry of Health, Labor and Welfare assumes that it can be given to people who have allergic reactions with conventional vaccines.



The Ministry of Health, Labor and Welfare is requesting prefectures to establish at least one vaccination site for this vaccine so that those who wish to receive the vaccine can receive the vaccine.



We plan to inoculate the second dose three weeks after the first dose, and after six months or more, we will be able to inoculate the third dose.



Takeda Pharmaceutical Company Limited is supposed to handle domestic production and distribution, and the contract is to supply 150 million doses to the Japanese government over the next year, and inoculation will start at the end of next month at the earliest.

Minister of Health, Labor and Welfare Goto "We have shown the local government a total of 100,000 deliveries from the end of next month."

At a press conference after the Cabinet meeting, Minister of Health, Labor and Welfare Goto said, "We will ensure the stability of vaccine supply in preparation for the possibility of export restrictions from overseas, and also based on the fact that it is a proven" recombinant protein vaccine ". We purchased 150 million doses last September to increase the variety of vaccine types. "


After that, "We have shown to the local government that we will deliver a total of 100,000 doses from the end of next month to the beginning of June, keeping in mind that people who are allergic to the'messenger RNA vaccine'will be vaccinated. We would like to firmly consider how to use it further, taking into account the content of future discussions at the council. "

Chief Cabinet Secretary “Domestic manufacturing leads to stable supply”

Chief Cabinet Secretary Matsuno said at a press conference after the Cabinet meeting, "The Novabax vaccine is currently in the process of being approved by the Ministry of Health, Labor and Welfare. We believe that it is desirable to be able to secure a variety of vaccines as well as to secure them because they are of a different type than before. We will continue to take appropriate measures to ensure that effective and safe vaccines are distributed to the general public. " I did.

Keywords: